Another highly significant result emerged from clinical applications of mitochondrial-targeted drugs in cancer therapies is that they have shown limited side-effects on normal “healthy” cell populations in vivo [ 148 ].
1
—
—
Another highly significant result emerged from clinical applications of mitochondrial-targeted drugs in cancer therapies is that they have shown limited side-effects on normal “healthy” cell populations in vivo [ 148 ].